Reproducibility of reversibility in airflow limitation over a year in clinically stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 62s Year: 2005
Reversibility of airflow limitation in elderly patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 336s Year: 2007
Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with TDI-induced asthma Source: Eur Respir J 2005; 26: Suppl. 49, 604s Year: 2005
Fixed airflow obstruction due to asthma or COPD: changes after five year follow up Source: Eur Respir J 2007; 30: Suppl. 51, 717s Year: 2007
Stability of fixed airflow limitation in patients with asthma: 1 year follow-up Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Asthmatics with persistent airway hyperresponsiveness showed deteriorations in AQLQ – a three year follow-up study Source: Eur Respir J 2006; 28: Suppl. 50, 668s Year: 2006
Determinants for the reversibility of airflow limitation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005
Impacts of bronchiectasis in asthma patients with airflow limitation Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Predictions of post-bronchodilator airflow obstruction by longitudinal asthma and wheeze patterns in middle-age Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021
Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Lung function decline in long-term follow-up of bronchial asthma Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010
FEV1 and MRI ventilation defect reversibility in asthma and COPD Source: Eur Respir J, 55 (3) 1901947; 10.1183/13993003.01947-2019 Year: 2020
Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
Comparison of changes of lung function in young children with stable bronchial asthma and exacerbation period by impulse oscillometry Source: Eur Respir J 2004; 24: Suppl. 48, 273s Year: 2004
Clinical and spirometric features of asthma patients with fixed airway obstruction Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD Source: Eur Respir J 2004; 24: 332 Year: 2004
Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry? Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children Year: 2018